These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 7715099

  • 1. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method].
    Hashimoto T, Matsumoto K, Ishibashi R, Iwasaki R, Sanmiya T, Hashimoto J, Kunieda E, Nakamura K, Kubo A.
    Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
    Adachi I, Sueyoshi K, Sugioka Y, Komori T, Ogura Y, Tabuchi K, Nakata Y, Namba R, Tatsu Y, Matsui R.
    Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of renal function using 99mTc-MAG3: comparison with 123I-OIH and 99mTc-DTPA].
    Takayama T, Aburano T, Shuke N, Yokoyama K, Michigishi T, Sun BF, Tonami N, Hisada K, Takabatake T, Ohta H.
    Kaku Igaku; 1993 Jul; 30(7):753-60. PubMed ID: 8377298
    [Abstract] [Full Text] [Related]

  • 4. [Phase 3 clinical study of 99mTc-MAG3 injectable, a dynamic renal imaging agent--comparison with 123I-OIH and 99mTc-DTPA].
    Torizuka K, Ishibashi A, Ikekubo K, Yamamoto K, Nishibuchi S.
    Kaku Igaku; 1994 Feb; 31(2):183-98. PubMed ID: 8121074
    [Abstract] [Full Text] [Related]

  • 5. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
    Sato M, Hirayama K, Ishikawa N, Takeda T, Wu J, Itai Y, Kobayashi M, Koyama A.
    Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
    [Abstract] [Full Text] [Related]

  • 6. [Usefulness of renal dynamic function study with 99mTc-MAG3 (mercaptoacetylglycylglycylglycine)].
    Shirakawa S, Tamaki N, Torizuka T, Fujita T, Yano S, Tsuchimochi S, Yonekura Y, Konishi J, Terai A.
    Kaku Igaku; 1994 Aug; 31(8):977-83. PubMed ID: 7933686
    [Abstract] [Full Text] [Related]

  • 7. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
    Lepej J, Marosová A, Kliment J, Buchanec J, Svitác J, Klisenbauer L.
    Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
    [Abstract] [Full Text] [Related]

  • 8. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
    Trejtnar F, Laznicek M, Laznickova A.
    Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
    [Abstract] [Full Text] [Related]

  • 9. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
    Koizumi K, Yamaguchi M, Tooyama K, Uchiyama G, Yamada Y, Ueno A.
    Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
    [Abstract] [Full Text] [Related]

  • 10. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A, Eshima D, Fritzberg AR, Christian PE, Kasina S.
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [Abstract] [Full Text] [Related]

  • 11. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I, Stiglich F, Barbonetti C, Bonomo F, Maspero S, Paini S, Bottinelli G.
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [Abstract] [Full Text] [Related]

  • 12. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L, Turoğlu HT, Onsel C, Ozker K, Uslu I, Atay S, Cansiz T, Sönmezoğlu K, Altiok E, Isitman AT.
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [Abstract] [Full Text] [Related]

  • 13. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
    Ozker K, Onsel C, Kabasakal L, Sayman HB, Uslu I, Bozluolçay S, Cansiz T, Kapicioğlu T, Urgancioğlu I.
    J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
    [Abstract] [Full Text] [Related]

  • 14. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
    Abdel-Dayem HM, Sadek S, al-Bahar R, Sabha M, el-Sayed M.
    Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
    [Abstract] [Full Text] [Related]

  • 15. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR, Robbins MS.
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [Abstract] [Full Text] [Related]

  • 16. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
    Jafri RA, Britton KE, Nimmon CC, Solanki K, Al-Nahhas A, Bomanji J, Fettich J, Hawkins LA.
    J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
    [Abstract] [Full Text] [Related]

  • 17. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U, Cordes M, Wilfling M, Hunger J, Hosten N, Gahl G.
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [Abstract] [Full Text] [Related]

  • 18. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
    Eshima D, Taylor A.
    Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
    [Abstract] [Full Text] [Related]

  • 19. Estimate of relative function and transit time in renographic studies.
    González A, Ros D, Pavia J.
    J Nucl Biol Med (1991); 1994 Sep; 38(3):502-7. PubMed ID: 7865547
    [Abstract] [Full Text] [Related]

  • 20. [Quantitative analysis of individual renal function using 99mTc-DMSA scintigram--comparison with 131I-OIH renogram].
    Komai S, Toyama H, Takeuchi A, Yokoyama K, Koga S.
    Kaku Igaku; 1995 Apr; 32(4):427-33. PubMed ID: 7776550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.